Report

Boiron : Avis a priori défavorable de l’HAS - Reprise de la cotation aujourd’hui – OC abaissé à 35 € - Alléger vs Neutre

>Avis défavorable de l’HAS sur le maintien d’un remboursement à 30% ? - La société avait demandé, jeudi soir, la suspension de sa cotation compte tenu de la possible fuite concernant l’avis que doit rendre l’HAS (la Haute Autorité de Santé) sur l’évaluation du service médical rendu de l’homéopathie. De cet avis dépendrait la révision (ou pas) du niveau de prise en charge et du remboursement obligatoire par l’Assurance-maladie (30% actuellement). Déplorant les con...
Underlying
Boiron SA

Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Other Reports on these Companies
Other Reports from Oddo BHF
Ghada Ben Sedrine ... (+2)
  • Ghada Ben Sedrine
  • Nicolas David
Benoit Valleaux ... (+5)
  • Benoit Valleaux
  • Roland Pfaender
  • MBA
  • CFA
  • CCRA
Ghada Ben Sedrine ... (+2)
  • Ghada Ben Sedrine
  • Nicolas David

ResearchPool Subscriptions

Get the most out of your insights

Get in touch